RESI Conference wants to connect early stage life sciences companies with investors

MaRS

MaRS, Life Science Nation, and JLABS (the newest innovation lab from Johnson & Johnson) are collaborating to host the Redefining Early Stage Investment (RESI) Conference in Toronto on June 23.

The RESI Conference series connects fundraising CEOs with early-stage investors from around the globe, with the goal of giving CEOs a chance to make valuable connections and possible secure funding. The event is focused on giving life sciences companies exposure to angels, VCs, government organizations, and venture philanthropy groups. Confirmed investors at the conference include BDC Capital, RBC Royal Bank, and the Ontario Centres of Excellence.

“MaRS supports over 250 Canadian-grown early stage health technology startups,” said Dianne Carmichael, managing director, health innovation & venture services at MaRS. “Our goal is to provide these young emerging ventures with the best connections to investors and industry to help them scale internationally. The RESI conference series has a strong track record of attracting global early stage investors. We’re delighted to bring them to MaRS this summer to build on the success of our HealthKick conferences.”

The conference will include 16 panel sessions with pharmaceutical, medical device, biotech, consumer health, and healthcare IT investors. At the same time, the company will host its MaRS HealthKick Challenge at RESI. The Dragons’ Den-inspired challenge selects 30 selected companies to demonstrate their technology and business while competing for prizes in a full-day exhibition to investors and potential partners.

To register for the event, check it out here.